Drug recall · March 26, 2025
Cinacalcet Hydrochloride Tablets 30 mg recall
Why: CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04
- Lots / codes
Lot # 07711, Exp 07/2025; 08900, Exp 09/2026; 08899, Exp 09/2026
- Quantity
- 56,790 bottles
- Company
- Slate Run Pharmaceuticals, Columbus, OH
- Distribution
- Product was distributed to 8 distributors who may have further distribute the product nationwide.
- Initiated
- March 7, 2025 · Voluntary: Firm initiated
- Classified
- March 17, 2025
- Reported
- March 26, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cinacalcet
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.